RxDoctor Payments Data

Valorie Mixon, PA

Physician Assistant · Chatsworth, GANPI 1285728006

Payments from drug & device makers

$1,994in general payments, 2019–2025

Across 111 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$326
  • Novo Nordisk$207
  • Lilly USA, LLC$174
  • GSK$166
  • AstraZeneca$153
  • Sumitomo Pharma America, Inc.$116
  • plus $853 from 21 others

What the payments were for

  • Food & beverage$1,994100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,994 in reported general payments places this provider in the 75th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$54,428
Medicare patients
180
Services billed
1,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide103$130,140
OzempicSemaglutide100$120,768
JardianceEmpagliflozin71$101,823
EliquisApixaban79$100,942
Austedo XrDeutetrabenazine12$91,125
Trelegy ElliptaFluticasone/Umeclidin/Vilanter80$78,760
TrulicityDulaglutide41$55,679
Tresiba Flextouch U-100Insulin Degludec33$45,095
RybelsusSemaglutide15$42,857
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog30$42,296
Tresiba Flextouch U-200Insulin Degludec20$39,947
FarxigaDapagliflozin Propanediol36$37,549
JanuviaSitagliptin Phosphate35$34,781
LinzessLinaclotide27$34,221
MyrbetriqMirabegron23$29,021

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$174$185,819144 claims
Novo NordiskOzempic, Rybelsus$207$163,625115 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$166$108,458148 claims
PfizerEliquis$106$100,94279 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$17$91,12512 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$153$69,57576 claims
AbbVieLinzess, Vraylar$326$55,00039 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Chatsworth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →